View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Valens Research
  • Valens Research

HOLX - Valens Credit Report - 2024 05 06

Credit markets are slightly overstating HOLX's credit risk with a YTW of 6.029% relative to an Intrinsic YTW of 5.409% and an Intrinsic CDS of 77bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with its speculative Ba1 credit rating three notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights positive signals for credit holders.HOLX's compensation framework incentivizes management to improve all three value drivers:...

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Daniel Thorsson
  • Simon Granath
Steven Boumans
  • Steven Boumans

PSP Swiss Property : Q1 2024 results: Strong results; partially driven...

>Beat in rental income and earnings driven by positive one-offs FY2024 outlook: EBITDA excl. gains/losses on RE investments increased to CHF 300m (was CHF 295m before), for a large extend due to one-off benefits.Like-for-like growth 6.6%, adjusted for two one-off effects 3.3% (FY2023 5.1%). Positive revaluations CHF 31.2m (FY2023 -161.3m or -1.7%). Regular revaluations are done semi-annually and changes in Q1 are due to property-specific changes.PSP d...

Klaus Ringel ... (+2)
  • Klaus Ringel
  • Michael Foundoukidis

NORMA Group SE : Q1 2024 profit margins showing further sequential imp...

>Q1 2024 results look broadly in line with our expectations - Norma’s Q1 2024 reported group sales are down 2% y-o-y to € 309m (in-line with ODDO BHF; -1% vs css) with an organic growth rate of -1%. Group adj. EBIT is +14% y-o-y to € 25.7m (+1% vs ODDO BHF& css) with an adj. EBIT margin of 8.3% in the quarter under review. The sequential improvement of Norma’s adj. EBIT margin (Q1 2023: 7.2%; Q4 2023: Q1 2024: 8.0%) is said to be driven by a more efficient production...

Stefano Toffano
  • Stefano Toffano

Solvay : A solid quarter despite the large net pricing headwinds

>Pressure on underlying EBITDA less than expected - A good first set of results for the new Solvay, with Q1 24 group revenues of € 1,201m (+6% vs ccs) reflecting -11.9% yoy organic growth mainly as a consequence of lower prices (-14.5% yoy), partially offset by higher volumes (+2.5% yoy). Q1 24 underlying EBITDA came in much stronger than expected at € 265m (-27.2% yoy, -13.6% organically given the exit from the thermal insulation and energy third parties operations) ...

 PRESS RELEASE

Suominen Corporation’s Interim Report for January 1 – March 31, 2024: ...

Suominen Corporation’s Interim Report for January 1 – March 31, 2024: Gradual improvement in profitability Suominen Corporation’s Interim Report on May 7, 2024, at 9:30 a.m. (EEST)Suominen Corporation’s Interim Report for January 1 – March 31, 2024: Gradual improvement in profitability  1-3/1-3/1-12/KEY FIGURES202420232023Net sales, EUR million113.6116.8450.9Comparable EBITDA, EUR million4.52.615.8Comparable EBITDA, %3.92.33.5EBITDA, EUR million4.72.611.2EBITDA, %4.12.32.5Comparable operating profit, EUR million-0.1-2.0-2.8Comparable operating profit, %-0.1-1.7-0.6Operating profit, EUR mil...

 PRESS RELEASE

Suominen Oyj:n osavuosikatsaus 1.1.-31.3.2024: Kannattavuus paranee as...

Suominen Oyj:n osavuosikatsaus 1.1.-31.3.2024: Kannattavuus paranee asteittain Suominen Oyj:n osavuosikatsaus 7.5.2024 klo 9.30Suominen Oyj:n osavuosikatsaus 1.1.-31.3.2024: Kannattavuus paranee asteittain AVAINLUKUJA  1-3/1-3/1-12/ 202420232023Liikevaihto, milj. euroa113,6116,8450,9Vertailukelpoinen käyttökate, milj. euroa4,52,615,8Vertailukelpoinen käyttökate, %3,92,33,5Käyttökate, milj. euroa4,72,611,2Käyttökate, %4,12,32,5Vertailukelpoinen liikevoitto, milj. euroa-0,1-2,0-2,8Vertailukelpoinen liikevoitto, %-0,1-1,7-0,6Liikevoitto, milj. euroa0,1-2,1-7,5Liikevoitto, %0,1-1,8-1,7Raporto...

 PRESS RELEASE

Cnova N.V. - Appointment of new non-executive director and Notice of t...

Cnova N.V. - Appointment of new non-executive director and Notice of the 2024 Annual General Meeting of Shareholders CNOVA N.V. Appointment of new non-executive director and Notice of the 2024 Annual General Meeting of Shareholders Amsterdam – May 7, 2024, 08:30 CEST — Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) announces that Mrs. Béatrice Davourie was appointed as replacement non-executive director and Chairman of the Board of Cnova NV, effective as per May 10, 2024. Mrs. Davourie serves as General Counsel at the Casino Group. Prior to joining Ca...

 PRESS RELEASE

Cnova N.V. - Nomination d’une nouvelle Administratrice non-exécutive e...

Cnova N.V. - Nomination d’une nouvelle Administratrice non-exécutive et Convocation à l’Assemblée Générale des actionnaires 2024 CNOVA N.V. Nomination d’une nouvelle Administratrice non-exécutive et Convocation à l’Assemblée Générale des actionnaires 2024 Amsterdam – Le 7 mai 2024, 8h30 CEST — Cnova N.V. (Euronext Paris : CNV ; ISIN : NL0010949392) (« Cnova » ou la « Société ») annonce que Mme Béatrice Davourie a été nommée en tant qu’Administratrice non-exécutive remplaçante et présidente du Conseil d’Administration de Cnova N.V., à compter du 10 mai 2024. Mme Davourie occupe le post...

 PRESS RELEASE

Sensorion Provides Preliminary Documents for the Combined Shareholders...

MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 29, 2024, at 2pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France. The prior notice of meeting comprising the agenda and draft resolutions...

 PRESS RELEASE

Sensorion met à disposition des documents préparatoires à l’Assemblée ...

MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Sensorion (FR0012596468 - ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce que les actionnaires de la Société sont invités à participer à l’Assemblée générale mixte qui se tiendra le mercredi 29 mai 2024 à 14h00 CET, dans les locaux de l’hôtel Square Louvois, situé 12, rue de Louvois, 75002 Paris, France. L’avis de réunion valant avis de convocation, comportant l’ordre du jour et les pro...

Valens Research
  • Valens Research

PBF - Valens Credit Report - 2024 04 22

Credit markets are overstating credit risk with a YTW of 6.853% relative to an Intrinsic YTW of 6.083% and an Intrinsic CDS of 139bps. Meanwhile, credit markets are materially overstating the firm's fundamental credit risk, with its Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As a positive, management members are material owners of PBF equity relative to their annual compensation,...

Valens Research
  • Valens Research

TDG - Valens Credit Report - 2024 04 26

Credit markets are overstating credit risk, with a cash bond YTW of 6.901% relative to an Intrinsic YTW of 6.001% and an Intrinsic CDS of 134bps. Furthermore, Moody's is materially overstating TDG's fundamental credit risk with its highly speculative B1 credit rating five notches below Valens' IG4 (Baa2) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for creditors. That said, most anagement members have low change-in-control compensation relative to thei...

First National Financial Corporation: 1 director

A director at First National Financial Corporation maiden bought 10,000 shares at 36.764CAD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Adrian Gilani

Clear margin improvement

21% EBITA beat vs. consensus mainly margin-driven. Lower costs and favourable mix to persist, EBITA up by 10-7%. Now trading at 17-15x '24e-'25e EV/EBITA.

Arnaud Autier ... (+2)
  • Arnaud Autier
  • Pierre Tegner

Remy Cointreau : Meeting between Emmanuel Macron and Xi Jinping: const...

>Outperform rating maintained with unchanged target price of € 125 - We are maintaining our Outperform rating, with an unchanged target price of € 125. The valuation remains attractive at 24x for NTM P/E, in absolute and relative terms, for a stock with high-quality fundamentals and which should return to growth in FY 2024-25e.The French business daily Les Echos yesterday published an article concerning Xi Jinping’s pledge to Emmanuel Macron to spare the French c...

Joan Sehim
  • Joan Sehim

Thyssenkrupp Elevator : Refinancing bonds is the next step

The company successfully executed an amend and extend transaction on the bulk of its term loan B during March. There is now less pressure regarding the refinancing of the remaining 2027/2028 debt wall, which could happen in the next 12 months and be facilitated by a rather positive outlook. Indeed, we see main credit metrics to improve more significantly in the next quarters, supported by the execution of cost savings, favorable pricing/mix dynamic and progressively declining one...

 PRESS RELEASE

Jyske Bank annoncerer nyt aktietilbagekøbsprogram

Jyske Bank annoncerer nyt aktietilbagekøbsprogram Bestyrelsen i Jyske Bank A/S (Jyske Bank) har besluttet at udnytte bemyndigelsen til at erhverve egne aktier givet på generalforsamlingen den 21. marts 2024. Aktietilbagekøbsprogrammet omfatter aktier for en maksimal værdi af 1,5 mia. kr. Programmet løber i perioden fra og med den 3. juni 2024 til senest den 31. januar 2025 efter bestemmelserne i EU’s markedsmisbrugsforordning, EU forordning nr. 596/2014 af 16. april 2014. Betingelser for aktietilbagekøbsprogrammet Formålet med programmet er en nedsættelse af aktiekapitalen i...

 PRESS RELEASE

Jyske Bank announces share repurchase programme

Jyske Bank announces share repurchase programme The Supervisory Board of Jyske Bank A/S (Jyske Bank) has decided to exercise the authority to repurchase shares granted by the Annual General Meeting on 21 March 2024. The share repurchase programme covers shares at a maximum value of DKK 1.5 billion. The programme runs as from 3 June 2024 and up to and including 31 January 2025. The share repurchase programme is initiated and structured in compliance with the EU Market Abuse Regulation and EU Commission Regulation No. 596/2014 of 16 April 2014. Conditions for the share repurchase pr...

 PRESS RELEASE

Interim Financial Report, Q1 2024

Interim Financial Report, Q1 2024 Net interest income rose by 11% to DKK 2,462m (Q1 2023: DKK 2,224m)Core income was up by 4% to DKK 3,430m (Q1 2023: DKK 3,310m)Core expenses rose by 5% to DKK 1,557m (Q1 2023: DKK 1,480m)Loan impairment charges amounted to an expense of DKK 82m (Q1 2023: DKK 96m)Net profit was nearly unchanged at DKK 1,286m (Q1 2023: DKK 1,289m).Capital ratio at 22.0%, of which common equity tier 1 capital ratio at 16.6% (Q1 2023: 19.6% and 15.4%, respectively)Dividend of DKK 500m, corresponding to DKK 7.78 per share, adopted at the Annual General Meeting and paid out to th...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch